Polypeptide Block Copolymer pH-Triggered Micelle Drug Delivery

Resolve Bottlenecks,
Find Innovative Solutions
Generate Solutions

Solution Overview

Problem

Current drug delivery systems face challenges in targeting specific pH environments within the body, such as those found in cancer cells, as existing pH-sensitive and biodegradable polymers either lack sensitivity to pH changes or have uncontrollable degradation rates, leading to inefficient drug release and potential toxicity from degradation products.

Innovation Solution

A polypeptide-based block copolymer is developed, incorporating a polyglutamic acid-based compound with a tertiary amine group that ionizes at pH 7.0 or lower, allowing for controlled degradation by peptidase, forming and collapsing micelles in response to pH changes between 6.5 and 7.0, enabling targeted drug release.

Engineering Contradictions & Design Principles

VSEngineering Contradiction Analysis

1Adaptability or versatility

If pH-sensitive polymers are used for target-oriented drug release, then drug delivery to specific areas is improved, but control of degradation rate is impossible

Engineering Contradiction:
ImprovepH sensitivityVSAvoiddegradation rate control
Core Design Contradiction:
Adaptability or versatilityVSDuration of action of moving object

Solution Approach 1:

The patent changes the chemical parameter of the polymer backbone from ester bonds to peptide bonds, which fundamentally alters the degradation mechanism from uncontrolled hydrolysis to enzyme-mediated degradation. This allows the degradation rate to be controlled by selecting different peptide sequences that vary in their susceptibility to peptidase enzymes, while maintaining pH sensitivity through the polyglutamic acid component's ionization behavior.

Inventive Principle:
Principle #35Parameter changes

Solution Approach 2:

The patent creates a composite block copolymer structure combining polyethylene glycol (hydrophilic) with polyglutamic acid derivatives (hydrophobic at physiological pH). This composite structure provides both pH sensitivity through the polyglutamic acid component and controlled biodegradability through the peptide backbone, resolving the contradiction between these two properties.

Inventive Principle:
Principle #40Composite materials

2Object-affected harmful factors

If biodegradable polymers are used for drug delivery, then biotoxicity is reduced, but target-oriented drug release is difficult

Engineering Contradiction:
ImprovebiotoxicityVSAvoidtarget-oriented drug release
Core Design Contradiction:
Object-affected harmful factorsVSAdaptability or versatility

Solution Approach 1:

The patent applies local quality by creating micelles with distinct functional regions: the polyethylene glycol corona provides biocompatibility and reduced biotoxicity, while the polyglutamic acid core provides pH sensitivity for target-oriented drug release. This spatial separation of functions allows both properties to coexist without compromise.

Inventive Principle:
Principle #3Local quality

3Stability of the object's composition

If polyethylene glycol and biodegradable polymer are used for micelle formation, then biodegradability is improved, but pH sensitivity is lost

Engineering Contradiction:
ImprovebiodegradabilityVSAvoidpH sensitivity
Core Design Contradiction:
Stability of the object's compositionVSAdaptability or versatility

Solution Approach 1:

The patent segments the polymer into distinct blocks with different functions: polyethylene glycol blocks provide biodegradability and biocompatibility, while polyglutamic acid blocks provide pH sensitivity. This segmentation allows each block to independently contribute its specific property to the overall micelle system.

Inventive Principle:
Principle #1Segmentation

Applied Scientific Principles

This section explains which scientific principles are used to turn an abstract innovation direction into a practical engineering solution.

Function Achieved in This Case

The polypeptide-based block copolymer achieves controlled drug release and reduced toxicity by forming and collapsing micelles at specific pH ranges, allowing for effective targeting of cancer cells while minimizing adverse effects from degradation products.

Implementation Method 1

incorporating a polyglutamic acid-based compound with a tertiary amine group that ionizes at pH 7.0 or lower

Methodology Applied
Scientific EffectIonization: Ionisation

Implementation Method 2

forming and collapsing micelles in response to pH changes between 6.5 and 7.0

Methodology Applied
Scientific EffectMicelle formation: Self-Assembly

Implementation Method 3

controlled degradation by peptidase

Methodology Applied
Scientific EffectPeptidase degradation: Enzyme

Data Source

PatentUS9180199B2Polypeptide based block copolymer and the process for the preparation thereof, and the polymer micelles using the same
Publication Date: 2015.11.10 RES & BUSINESS FOUND SUNGKYUNKWAN UNIV
  • US9180199B2 patent drawing
  • US9180199B2 patent drawing
  • US9180199B2 patent drawing

AI summary

A polypeptide based block copolymer having biodegradability due to peptidase, a process for the preparation thereof, and polymer micelles using the same are provided. The block copolymer is a block copolymer of a polyethylene glycol-based compound having properties such that the solubility for water is different depending on the pH, but cannot form micelles due to a self-assembly phenomenon; and a polyglutamic acid-based compound formed using an aminolysis reaction of glutamic acid and tertiary amine in which the end of one alkyl group is substituted with NH2, or using an aminolysis reaction of glutamic acid and triamine.